Exact Mass: 463.239

Exact Mass Matches: 463.239

Found 38 metabolites which its exact mass value is equals to given mass value 463.239, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

trans-Epothilone C1

trans-Epothilone C1

C25H37NO5S (463.2392)


   
   
   
   

Arg Ser Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Arg Thr Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Arg Thr Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H33N7O8 (463.239)


   

Ser Arg Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Ser Thr Arg Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Ser Thr Thr Arg

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C17H33N7O8 (463.239)


   

Thr Arg Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Thr Arg Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C17H33N7O8 (463.239)


   

Thr Ser Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C17H33N7O8 (463.239)


   

Thr Ser Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C17H33N7O8 (463.239)


   

Thr Thr Arg Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C17H33N7O8 (463.239)


   

Thr Thr Ser Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C17H33N7O8 (463.239)


   

PCTR3

16R-(S-cysteinyl)-17S-hydroxy-4Z,7Z,10Z,12E,14E,19Z-docosahexaenoic acid

C25H37NO5S (463.2392)


   

MCTR3

13R-(S-cysteinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

C25H37NO5S (463.2392)


   

(2S)-(-)-2,2-OXYBIS(OCTAHYDRO-7,8,8-TRIMETHYL-4,7-METHANOBENZOFURAN)

(2S)-(-)-2,2-OXYBIS(OCTAHYDRO-7,8,8-TRIMETHYL-4,7-METHANOBENZOFURAN)

C25H37NO5S (463.2392)


   

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid

C25H37NO5S (463.2392)


   

(4Z,7Z,16S,17R,19Z)-16-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-17-hydroxydocosa-4,7,10,12,14,19-hexaenoic acid

(4Z,7Z,16S,17R,19Z)-16-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-17-hydroxydocosa-4,7,10,12,14,19-hexaenoic acid

C25H37NO5S (463.2392)


   

16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid

C25H37NO5S (463.2392)


A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a glycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialised proresolving mediators

   

(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

(13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid

C25H37NO5S (463.2392)


A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinyl group is attached at position 13R via a sulfide linkage.

   
   

(4s,5r,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,5r,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,8r,9s,13z,16s)-4,8-dihydroxy-5,5,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,8r,9s,13z,16s)-4,8-dihydroxy-5,5,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,7r,8s,9r,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,9r,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

4,8-dihydroxy-5,7,9-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

4,8-dihydroxy-5,7,9-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,7r,8s,13z,16s)-4,8-dihydroxy-5,5,7-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,13z,16s)-4,8-dihydroxy-5,5,7-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,5s,7r,8s,9s,13e,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,5s,7r,8s,9s,13e,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

4,8-dihydroxy-5,5,7,9-tetramethyl-16-[2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

4,8-dihydroxy-5,5,7,9-tetramethyl-16-[2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

4,8-dihydroxy-5,5,7-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

4,8-dihydroxy-5,5,7-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

4,8-dihydroxy-5,5,9-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

4,8-dihydroxy-5,5,9-trimethyl-16-[1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,5r,7r,8s,9s,13e,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,5r,7r,8s,9s,13e,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,7r,8s,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,13z,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)


   

(4s,5s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,5s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,7,9-trimethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C25H37NO5S (463.2392)